publication date: May. 27, 2016

Conversation with The Cancer Letter

Johnson: A New Vision for Roswell Park 


Since Candace Johnson’s appointment as president and CEO of the Roswell Park Cancer Institute in February 2015, the institute has recruited 22 new faculty members and promoted 19 faculty members into senior leadership positions.

“I’m a new leader. I have a new style, a new vision of where Roswell Park is going,” Johnson, the Wallace Family Chair in Translational Research, said to The Cancer Letter. “We have new and different challenges, and unless my entire workforce understood these challenges and embraced the changes I’ve been implementing, we wouldn’t have a chance.”

The full list of Roswell Park’s new appointments appears here.

Based in Buffalo, N.Y., the 118-year-old comprehensive cancer center is the only NCI-designated center in the state outside of New York City and Long Island.

Prior to becoming president and CEO, Johnson was the deputy director and chair of the Department of Pharmacology and Therapeutics. She has also served as cancer center director for the institute since November 2014.

Johnson has led the scientific strategies and achievements of Roswell Park for 13 years. Before coming to Roswell Park, she served as deputy director of basic research at the University of Pittsburgh Cancer Institute, and professor of pharmacology and medicine at the University of Pittsburgh School of Medicine.

Johnson spoke with Paul Goldberg, editor … Continue reading 42-21 Conversation with The Cancer Letter – Johnson: A New Vision for Roswell Park

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.